NCT05248438

Brief Summary

The investigators want to evaluate gynecological follow-up concerning patients with multiple sclerosis. This study will include reproductive women (from 18 to 40 years old). Patients in the study have an aftercare at the neurology department at Pellegrin Hospital (Bordeaux).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 21, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 11, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2023

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

12 months

First QC Date

February 11, 2022

Last Update Submit

June 9, 2023

Conditions

Keywords

multiple sclerosisgynecological caresexualitycontraception

Outcome Measures

Primary Outcomes (1)

  • Gynecological scores of women from 18 to 40 years old with multiple sclerosis with a standardized questionnaire created for the study.

    17 questions concerning contraception, number of gynecological follow up, frequency of cervical cancer screening, desire of pregnancy.

    At baseline (Day 0)

Secondary Outcomes (4)

  • Proportion of patients affected by SEP with an Impact on sexuality according to Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-19).

    At baseline (Day 0)

  • Proportion of patients affected by SEP with an impact on life quality according to Fatigue severity Scale (FFS).

    At baseline (Day 0)

  • Proportion of patients affected by SEP with an impact on life quality according to EHD scores ("échelle d'humeur dépressive" in french)

    At baseline (Day 0)

  • Proportion of patients affected by SEP with an impact on life quality according to Multiple Sclerosis Quality of life (MusiQol) scores

    At baseline (Day 0)

Study Arms (1)

Multiple sclerosis patients

patients affected by multiple sclerosis based on McDonald Criteria 2017

Behavioral: Questionnaire

Interventions

QuestionnaireBEHAVIORAL

Questionnaire

Multiple sclerosis patients

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patient Aged between 18 to 40 years old, affected by multiple sclerosis based on McDonald Criteria 2017

You may qualify if:

  • Aged between 18 to 40 years old ;
  • Diagnosis of multiple sclerosis based on McDonald Criteria 2017 ;
  • Patient whose clinical data are referenced in the European Database for Multiple Sclerosis (EDMUS) clinical database (OFSEP database for collecting clinical data from patients followed in the neurology department) ;
  • French-speaking, without comprehension disorders ;
  • being affiliated to health insurance ;
  • Willing to participate and to sign informed consent.

You may not qualify if:

  • pregnant or breastfeeding women ;
  • patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Bordeaux - service de neurologie

Bordeaux, France

Location

Related Publications (1)

  • Renaud J, Buissonniere P, Dulau C, Deloire M, Hontarrede F, Montcuquet A, Chansel-Debordeaux L, Hocke C, Ouallet JC, Ruet A, Bernard V. Gynaecological follow-up for women of reproductive age with multiple sclerosis: The GYNESEP study. Mult Scler Relat Disord. 2024 Mar;83:105448. doi: 10.1016/j.msard.2024.105448. Epub 2024 Jan 14.

MeSH Terms

Conditions

Multiple SclerosisSexuality

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSexual BehaviorBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Valérie BERNARD, MD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2022

First Posted

February 21, 2022

Study Start

May 11, 2022

Primary Completion

May 9, 2023

Study Completion

May 9, 2023

Last Updated

June 12, 2023

Record last verified: 2023-06

Locations